6IO Stock Overview
A medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Inogen, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$9.40 |
| 52 Week High | US$11.60 |
| 52 Week Low | US$4.56 |
| Beta | 1.04 |
| 11 Month Change | 13.94% |
| 3 Month Change | -16.81% |
| 1 Year Change | 80.77% |
| 33 Year Change | -68.03% |
| 5 Year Change | -85.86% |
| Change since IPO | -95.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6IO | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -5.1% | -4.9% | -1.5% |
| 1Y | 80.8% | -5.6% | 7.9% |
Return vs Industry: 6IO exceeded the German Medical Equipment industry which returned -4.2% over the past year.
Return vs Market: 6IO exceeded the German Market which returned 8.3% over the past year.
Price Volatility
| 6IO volatility | |
|---|---|
| 6IO Average Weekly Movement | 5.8% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6IO has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 6IO's weekly volatility has decreased from 11% to 6% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 834 | Kevin R. Smith | www.inogen.com |
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories.
Inogen, Inc. Fundamentals Summary
| 6IO fundamental statistics | |
|---|---|
| Market cap | €227.38m |
| Earnings (TTM) | -€50.05m |
| Revenue (TTM) | €314.91m |
0.7x
P/S Ratio-4.3x
P/E RatioIs 6IO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6IO income statement (TTM) | |
|---|---|
| Revenue | US$331.52m |
| Cost of Revenue | US$184.91m |
| Gross Profit | US$146.61m |
| Other Expenses | US$199.30m |
| Earnings | -US$52.69m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.21 |
| Gross Margin | 44.22% |
| Net Profit Margin | -15.89% |
| Debt/Equity Ratio | 0% |
How did 6IO perform over the long term?
See historical performance and comparison